You are here

palovarotene

Ipsen scraps pivotal trial as partial clinical hold drags on

Ipsen scraps pivotal trial as partial clinical hold drags on

Fierce Biotech

clinical trials

osteochondromas

Flag link:

Ipsen takes €669M hit as palovarotene's prospects wither

Ipsen takes €669M hit as palovarotene's prospects wither

Fierce Biotech

Flag link:

Ipsen’s quick fix backfires

Ipsen’s quick fix backfires

EP Vantage

Flag link:

With clear FDA path, Clementia raises $70.2M

With clear FDA path, Clementia raises $70.2M

BioCentury

Clementia Pharmaceuticals

fibrodysplasia ossificans progressiva

Flag link:

Clementia jumps on NDA plans for unmet rare bone disease

Clementia jumps on NDA plans for unmet rare bone disease

BioCentury

Clementia Pharmaceuticals

Flag link: